A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Safety and Efficacy Study Evaluating CS-101 in Participants With β-Thalassemia Major	β-thalassemia Major	Not yet recruiting	Phase 2	2026-03-24		NCT07489196

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CorrectSequence Therapeutics Co., Ltd	8

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Children's Hospital of Fudan University	Shanghai	China	20
Ruijin Hospital Shanghai Jiaotong University School of Medicine	Shanghai	China	3
The First Affiliated Hospital of Guangxi Medical University	Nanning	China	33

Clinical trials